2010 Annual Meeting
Session: Disease Therapies
This session welcomes contributions addressing the evaluation of therapeutic efficacy of drug delivery systems, stents, or tissue engineered scaffolds. The focus should be on their actual therapeutic potential. Contributions concerning mathematical modeling (or dosimetry) accompanying the above, or suggesting alternative strategies, are also welcome.
Chair
Tzanakakis, M. S., State University of New York at Buffalo
Co-Chair
Harrison, R., University of Oklahoma